Akèy › Kansè Poumon ki pa ti selil › North Carolina › Greenville
Etid klinik pou Kansè Poumon ki pa ti selil nan Greenville, NC
3 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Greenville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Ap rekriteFaz 3
- Brody School of Medicine at East Carolina University, Greenville
- ECU Health Medical Center, Greenville
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Ap rekriteFaz 3
- Research Site, Greenville
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Ap rekriteFaz 3
- East Carolina University, Greenville
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY121 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH57 etid
- Washington, DC55 etid
Lòt etid nan Greenville
- Leksemi mieloïd egi10 etid
- Maladi selil fòs9 etid
- Pirura Trombositopenik Idyopatik6 etid
- Ensifizyans kadyak6 etid
- Lukemi lenfositè kwonik5 etid
- Limfòm Burkitt5 etid
- Obèsite5 etid
- Dyabèt Tip 25 etid
- Twoub san5 etid
- Kansè (tout kalite)4 etid
- Maladi otoim4 etid
- Neoplazmi myeloproliferatif4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.